P3 Health Partners Inc (PIII)
0.5372
+0.07
(+14.71%)
USD |
NASDAQ |
Apr 30, 16:00
0.55
+0.01
(+2.38%)
After-Hours: 20:00
P3 Health Partners Free Cash Flow (Quarterly): -15.67M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.67M |
| September 30, 2023 | -7.973M |
| June 30, 2023 | -30.03M |
| March 31, 2023 | -24.19M |
| December 31, 2022 | -31.90M |
| September 30, 2022 | -21.86M |
| Date | Value |
|---|---|
| June 30, 2022 | -45.84M |
| March 31, 2022 | -28.65M |
| September 30, 2021 | -6.802M |
| June 30, 2021 | -22.24M |
| March 31, 2021 | -13.78M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-45.84M
Minimum
Jun 2022
-6.802M
Maximum
Sep 2021
-22.63M
Average
-22.24M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| American Shared Hospital Services | -3.157M |
| Novo Integrated Sciences Inc | -1.714M |
| Astrana Health Inc | 12.24M |
| Cryo-Cell International Inc | -0.8146M |
| Biote Corp | 5.952M |